由寄生性线虫布鲁吉亚malayi分泌的微RNA破坏了淋巴细胞内皮细胞完整性
Hailey Johnson1, Stephanie Banakis1, Matthew Chung1
1Systems Genomics Section, Laboratory of Parasitic Diseases, Division of Intramural Research, NIAID, NIH, Bethesda, Maryland, United States of America.
PLoS neglected tropical diseases
|December 31, 2024
概括
来自Brugia malayi的寄生性microRNAs (miRNAs) 可以增加淋巴血管的透性,从而导致淋巴腺病 (LF) 的病理. 这一发现可能会导致新的诊断工具和LF的治疗方法.
科学领域:
- 寄生虫学的寄生虫学
- 分子生物学分子生物学
- 热带医学 热带医学
背景情况:
- 淋巴状细菌病 (LF) 是一种由寄生虫线虫引起的令人衰弱的被忽视的热带疾病.
- 慢性LF感染导致严重的疾病,如淋巴和象牙病.
- 了解寄生虫与宿主之间的相互作用对于管理LF病理至关重要.
研究的目的:
- 研究寄生虫分泌的Brugia malayi微RNAs (miRNAs) 在LF病变发生过程中的作用.
- 识别影响淋巴内皮细胞完整性的特定寄生虫miRNAs.
- 探索这些miRNAs的潜在诊断和治疗应用.
主要方法:
- 用B. malayimiRNAs (bma-miR-5864和bma-miR-86) 治疗的人类淋巴内皮细胞的体外转录学分析.
- 评估miRNAs对调节内皮细胞完整性的蛋白质的影响.
- 测量内皮单层透性的变化.
主要成果:
- 鉴定了寄生虫分泌的miRNAs,这些miRNAs降低了对淋巴内皮细胞完整性至关重要的蛋白质的下调.
- 证明这些miRNAs显著增加内皮透气性.
- 确认大量分泌布鲁吉亚特异性和线虫特异性小RNA.
结论:
- 寄生虫衍生的miRNAs通过损害淋巴细胞内皮细胞完整性,导致LF病理.
- 这些发现为新型LF诊断标志物和治疗点提供了潜力.
- 抑制寄生虫miRNAs可能是一种减缓LF进展的策略.
相关概念视频
Fungal Phylum Microsporidia
Microsporidia are a group of obligate intracellular fungi that were initially classified as protists but were later reclassified based on phylogenetic, molecular, and structural evidence linking them to the Chytridiomycota. These unicellular, non-motile organisms are highly specialized parasites that infect a wide range of animal hosts, including humans. They have evolved extensive genomic and metabolic reductions, making them highly dependent on their hosts for survival.Morphology and Genomic...
Microbial Interactions: Parasitism
Parasitism is a form of microbial interaction in which parasitic microbes exploit a host organism for nutrients and shelter, often at the host's expense. Unlike mutualistic relationships, where both organisms benefit, parasitism benefits only the parasite and harms the host.Classification of ParasitesMicrobial parasites are broadly classified based on their location relative to the host.Ectoparasites remain on the host’s surface, such as the skin or outer tissues, drawing nutrients...
Leishmaniasis
Leishmaniasis is a protozoal disease caused by species of the genus Leishmania and transmitted through the bite of infected female sandflies. The parasite exists in two principal morphological forms during its life cycle. A sandfly acquires intracellular amastigotes from an infected reservoir host, such as a dog. Within the sandfly, these forms differentiate into motile, flagellated promastigotes. During a subsequent blood meal, promastigotes are injected into the human host, where they...
Amebiasis
Entamoeba histolytica, a protozoan parasite, is responsible for intestinal and extraintestinal amebiasis. Though a significant proportion of infections remain asymptomatic, approximately 50 million individuals annually are estimated to present with clinical disease, resulting in up to 100,000 deaths globally. The disease burden is disproportionately high in regions with lower socioeconomic status, such as parts of India, Africa, Mexico, and Latin America.Etiology and TransmissionThe infective...
Anthelminthic Agents
Anthelmintic drugs differ significantly from antiparasitic therapies targeting protozoa, primarily due to differences in parasite biology. Whereas most protozoal treatments act on proliferating cells, anthelmintics are typically directed against mature, nonproliferative helminths. The therapeutic approach considers the helminth's reliance on neuromuscular coordination, glucose metabolism, and microtubular integrity for survival, reproduction, and localization within the host. Most anthelmintics...


